Charles River Laboratories International, Inc. (CRL) income statement
CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30215% above fair value
$333.25+1.09 (+0.33%)
Close on Nov 18, 2026Market cap $15.91BP/E –Yield –
Charles River Laboratories International, Inc. income statement
Ratios
Latest available, balances at Jun 27, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- 2.3%
- Net margin
- -6.0%
- Return on equity, FY2025
- -4.4%
Financial strength
- Current ratio
- 1.35
- Debt to equity
- 0.92
- Debt to assets
- 34.9%
- Cash to current liabilities
- 16.9%
Valuation
- P/E ratio
- –
- Price to sales
- 3.98
- Price to book
- 5.60
- Dividend yield
- –
See a number that looks wrong?